ZEAL Associate Corp.
329A.T
Tokyo Stock Exchange2,116.00
JPY
- -
- -
ZEAL Associate Corp.
329A.T
(Tokyo Stock Exchange)
Recent
price
2,116.00
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- ZEAL Associate Corp. engages in the development and provision of pharmaceutical and healthcare technology solutions, with a focus on data-driven patient care products and related services. The company offers a comprehensive portfolio of main products and services including patient management and monitoring platforms; clinical data analytics and decision-support tools; health information systems and interoperability solutions; laboratory information management and diagnostics support services; revenue cycle and medical billing solutions; and regulatory compliance and risk management services. It operates across multiple product lines under clearly defined categories such as software as a service platforms for hospitals and clinics, on-premise and cloud-based health IT systems, data integration and analytics modules, and specialized applications for pharmacovigilance, clinical trial support, and population health management. ZEAL Associate Corp. markets its offerings to healthcare providers, life sciences companies, payers, and research organizations, enabling improved clinical outcomes, operational efficiency, and data-driven decision making. The company’s geographic footprint spans Japan and other Asia-Pacific markets, with further distribution through international partnerships and subsidiaries to serve global health clients. ZEAL Associate Corp. is publicly traded under the ticker 329A.T and maintains its headquarters in Tokyo, Japan. The company was founded in 2010 and pursues ongoing expansion through partnerships, strategic alliances, and targeted acquisitions to enhance its product suite and geographic reach. Recent developments include strategic partnerships with regional healthcare networks to expand deployment of its hospital information and analytics platforms; targeted investments to accelerate AI-enabled clinical insights; launch of new cloud-native versions of its health IT solutions; and organizational restructurings to integrate its software, data services, and services businesses under a unified operating framework. These changes reflect ZEAL Associate Corp.’s continuing growth strategy, enhanced product integration, and broadened service capabilities to address evolving healthcare market needs. The industry segments include health IT systems, clinical analytics, medical data services, and revenue cycle management, with primary customers comprising hospitals, clinics, research institutes, pharmaceutical firms, and health insurers seeking advanced data capabilities and improved care delivery. Subsidiaries and parent relationships support regional service delivery and enable cross-border data exchange under strict privacy and security standards.